These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34615436)
1. Decreased SLC39A1 (Solute carrier family 39 member 1) expression predicts unfavorable prognosis in patients with early-stage hepatocellular carcinoma. Zhang Q; Pan J; An F; Nie H; Zhan Q Bioengineered; 2021 Dec; 12(1):8147-8156. PubMed ID: 34615436 [TBL] [Abstract][Full Text] [Related]
2. Low expression of organic anion-transporting polypeptide 1B3 predicts a poor prognosis in hepatocellular carcinoma. Chen S; Li K; Jiang J; Wang X; Chai Y; Zhang C; Deng Q; Shuai L; Feng K; Ma K; Zhang L World J Surg Oncol; 2020 Jun; 18(1):127. PubMed ID: 32534581 [TBL] [Abstract][Full Text] [Related]
3. Expression and prognostic significance of epithelial tissue-specific transcription factor ESE3 in hepatocellular carcinoma. Lyu Z; Ma M; Xu Y; Wang X; Zhu Y; Ren W; Li T Int J Clin Oncol; 2020 Jul; 25(7):1334-1345. PubMed ID: 32347431 [TBL] [Abstract][Full Text] [Related]
4. Overexpression of EWSR1 (Ewing sarcoma breakpoint region 1/EWS RNA binding protein 1) predicts poor survival in patients with hepatocellular carcinoma. Jiang W; Wu T; Shi X; Xu J Bioengineered; 2021 Dec; 12(1):7941-7949. PubMed ID: 34612781 [TBL] [Abstract][Full Text] [Related]
5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
6. Decreased Expression of ZWINT is Associated With Poor Prognosis in Patients With HCC After Surgery. Yang XY; Wu B; Ma SL; Yin L; Wu MC; Li AJ Technol Cancer Res Treat; 2018 Jan; 17():1533033818794190. PubMed ID: 30198401 [TBL] [Abstract][Full Text] [Related]
7. [Dysplastic nodule of liver versus early hepatocellular carcinoma: a clinicopathologic and prognostic study]. Chen L; Tan Y; Zeng H; Hou Y; Xu J; Zhao J; Ji Y Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):301-6. PubMed ID: 25030861 [TBL] [Abstract][Full Text] [Related]
8. A 4-gene prognostic signature predicting survival in hepatocellular carcinoma. Chen PF; Li QH; Zeng LR; Yang XY; Peng PL; He JH; Fan B J Cell Biochem; 2019 Jun; 120(6):9117-9124. PubMed ID: 30582205 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis. Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of cytoskeleton-associated membrane protein 4 and its palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma. Li SX; Tang GS; Zhou DX; Pan YF; Tan YX; Zhang J; Zhang B; Ding ZW; Liu LJ; Jiang TY; Hu HP; Dong LW; Wang HY Cancer; 2014 May; 120(10):1520-31. PubMed ID: 24863391 [TBL] [Abstract][Full Text] [Related]
11. ITPKA expression is a novel prognostic factor in hepatocellular carcinoma. Li J; Zhu YH; Huang P; Zhang B; Sun J; Guan XY Diagn Pathol; 2015 Aug; 10():136. PubMed ID: 26249031 [TBL] [Abstract][Full Text] [Related]
12. Transcriptional analysis of the expression, prognostic value and immune infiltration activities of the COMMD protein family in hepatocellular carcinoma. Wang X; He S; Zheng X; Huang S; Chen H; Chen H; Luo W; Guo Z; He X; Zhao Q BMC Cancer; 2021 Sep; 21(1):1001. PubMed ID: 34493238 [TBL] [Abstract][Full Text] [Related]
13. Loss of Wnt5a and Ror2 protein in hepatocellular carcinoma associated with poor prognosis. Geng M; Cao YC; Chen YJ; Jiang H; Bi LQ; Liu XH World J Gastroenterol; 2012 Mar; 18(12):1328-38. PubMed ID: 22493546 [TBL] [Abstract][Full Text] [Related]
14. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients. Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282 [TBL] [Abstract][Full Text] [Related]
16. Aberrant KIF20A expression might independently predict poor overall survival and recurrence-free survival of hepatocellular carcinoma. Lu M; Huang X; Chen Y; Fu Y; Xu C; Xiang W; Li C; Zhang S; Yu C IUBMB Life; 2018 Apr; 70(4):328-335. PubMed ID: 29500859 [TBL] [Abstract][Full Text] [Related]
17. Combined Chibby and β-Catenin Predicts Clinical Outcomes in Patients with Hepatocellular Carcinoma. Tsai MC; Huang CC; Wei YC; Liu TT; Lin MT; Yi LN; Lin PR; Wang CC; Chu TH; Hsiao CC; Hu TH; Tai MH Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192213 [TBL] [Abstract][Full Text] [Related]
18. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma. Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256 [TBL] [Abstract][Full Text] [Related]
19. The Overexpression of CCAR1 in Hepatocellular Carcinoma Associates with Poor Prognosis. Ha SY; Kim JH; Yang JW; Kim J; Kim B; Park CK Cancer Res Treat; 2016 Jul; 48(3):1065-73. PubMed ID: 26511806 [TBL] [Abstract][Full Text] [Related]
20. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis. Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]